Knight Therapeutics Inc - ESG Rating & Company Profile powered by AI
The Disclosure rating covers seventeen UN Sustainable Development Goals including: 'No Poverty', 'Responsible Production & Consumption' and 'Peace, Justice & Strong Institutions'. Full Sustainability assessment of Knight Therapeutics Inc are accessed by registering for free. The Sustainability assessment for Knight Therapeutics Inc represents the company's transparency towards the United Nations SDGs.
Knight Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.7; made up of an environmental score of 6.0, social score of 8.0 and governance score of 3.2.
5.7
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 541 | Wntresearch AB | 5.8 | High |
| 541 | Zenotech Laboratories Ltd | 5.8 | High |
| 579 | Knight Therapeutics Inc | 5.7 | High |
| 579 | Caplin Point Laboratories Ltd | 5.7 | High |
| 579 | Biotest AG | 5.7 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Knight Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Knight Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Knight Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Knight Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Knight Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Knight Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Knight Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Knight Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Knight Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Knight Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Knight Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Knight Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Knight Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Knight Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Knight Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Knight Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Knight Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Knight Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Knight Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Knight Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Knight Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Knight Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Knight Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Knight Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Knight Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Knight Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Knight Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Knight Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Knight Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Knight Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Knight Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Knight Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Knight Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Knight Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Knight Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Knight Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Knight Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Knight Therapeutics Inc., a specialty pharmaceutical company, develops, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices in Canada, Latin America, and internationally. It offers Nerlynx for extended adjuvant breast cancer and metastatic breast cancer; Tafasitamab for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib to treat metastatic cholangiocarcinoma; Trelstar for advanced prostate cancer and for pain associated with endometriosis; Vidaza for myelodysplastic syndrome; Abraxane for metastatic pancreatic adenocarcinoma; Halaven for metastatic breast cancer and doft tissue sarcoma; and Lenvima for differentiated thyroid cancer, advanced renal cell cancer, and unresectable hepatocellular carcinoma. The company also provides Ladevina for multiple myeloma, myelodysplastic syndrome, mantle cell lymphoma, and follicular lymphoma; Zyvalix for metastatic prostate cancer; Karfib for relapsed or refractory multiple myeloma; Leprid for advanced prostate cancer; Rembre for chronic myeloid leukemia; Ambisome and Cresemba for fungal infection; Impavido for leishmaniasis; Exelon for mild to moderately severe dementia; and Ibsrela for the treatment of irritable bowel syndrome with constipation. In addition, it offers Salofalk for ulcerative colitis; Ursofalk to treat biliary cirrhosis; Imvexxy for moderate to severe dyspareunia; Bijuva for moderate to severe vasomotor symptoms associated with menopause in women with intact uteri; Fibridoner to treat idiopathic pulmonary fibrosis; Toliscrin DPI for pseudomonas aeruginosa lung infection in patients with cystic fibrosis; Toliscrin 1-2 for severe acute or resistant chronic infections; and Tobradosa Haler for chronic lung infections. Further, the company finances other life science companies; and invests in life sciences venture capital funds. Knight Therapeutics Inc. was incorporated in 2013 and is headquartered in Montreal, Canada.